October 9, 2024
Using one dose of the human papillomavirus (HPV) vaccine is as effective in preventing cervical cancer as two or three doses, new research suggests.
A peer-reviewed study published in the Canadian Medical Association Journal (CMAJ) on Monday found that a single dose of HPV vaccine could prevent a similar number of cervical cancers, HPV infections and other HPV-related cancers as a two-dose program among men and women in Canada.
This is if vaccine protection remains high during ages of peak sexual activity, the study states.
The clinical data supporting this was strong for people aged nine to 20 years, said Dr. Chantal Sauvageau, study co-author and public health physician at the National Institute of Public Health of Quebec.
Read more: https://globalnews.ca/news/10802571/hpv-vaccine-dosage-canada-study/